References
- Colditz G A, Willctt W C, Stampfer M J, Rosner B, Speizer F E, Hennekens C H. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 361: 1105–10
- Heiss G, Tamir I, Davis C E, Tyroler H A, Rifkind B M, Schonfeld G, Jacobs D, Frantz I D. Lipoprotein cholesterol distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. Circulation 1980; 61: 301–15
- Wallace R B, Hoover J, Barrett-Connor E, Rifkind B M, Hunninghake D B, Mackenthun A, Heiss G. Altered plasma lipid and lipoprotein levels associated with oral contraceptive and estrogen use. Lancet 1979; ii: 111–5
- Bradley D D, Wingerd J, Petitti D B, Krauss R M, Ramcharan S. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N Engl J Med 1978; 299: 17–20
- Henriksson P, Stamberger M, Eriksson M, Rudling M, Diczfalusy U, Berglund L, Angelin B. Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbit. Eur J Clin Invest 1989; 19: 395–403
- Kushwaha R S, Hazzard W R. Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit. Metabolism 1981; 30: 359–66
- Hough J L, Zilversmit D B. Effect of 17 -estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis 1986; 6: 57–63
- Hirvonen E, Malkonen M, Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med 1981; 5: 560–3
- Hurley B F, Seals D R, Hagberg J M, Goldberg A C, Ostrove S M, Holloszy J O, Wiest W G, Goldberg A P. High-density-lipoprotein cholesterol in bodybuilders v powerlifters. J Am Med Assoc 1984; 4: 507–13
- Taggart H, Applebaum-Bowdcn D, Haffner S, Russcl-Warnick G, Cheung M C, Albers J J, Chestnut C H, III, Hazzard R. Reduction in high density lipoproteins by anabolic steroid (Stano-zolol) therapy for postmenopausal osteoporosis. Metabolism 1982; 31(11)1147–52
- Haffner S M, Kushwaha R S, Foster D M, Apple-baum-Bowden D, Hazzard W R. Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy. Metabolism 1983; 32(4)413–20
- Tikkanen M J, Nikkila E A, Kuusi T, Sipinen S. High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel. J Clin Endocrin Metabol 1982; 54(6)1113–7
- Weibel E R. Stereological Methods. Academic Press, London 1979; vol 1